Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.
about
Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementationIs Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin?Commentary: Comparison of historical medical spending patterns among the BRICS and G7Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America.Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.Science, technology, power and sex: PrEP and HIV-positive gay men in Paris.Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.PrEP implementation: moving from trials to policy and practice.PrEP Implementation Science: State-of-the-Art and Research Agenda.Can we afford to offer pre-exposure prophylaxis to MSM in Catalonia? Cost-effectiveness analysis and budget impact assessment.Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
P2860
Q36296707-771B0A85-481A-464D-BB64-6CF9078A2C8BQ36591180-43BFF7D0-293F-43EB-86C0-1A2087D19E52Q37092539-E3C3C07C-00E6-4838-9F4A-27E0FC498BC3Q37352485-A314DB9B-4C25-4E0C-8D32-E74C4B5F72E0Q37352568-85D394E2-CCDA-4F51-B64B-E2B3DC92B06CQ38918530-CBC64665-D6DE-422F-8DBF-9AB8A5771D44Q40446068-CBEFDCA8-D956-4103-9501-E69501ACE8E8Q42104687-FBD24AC2-EC6D-46A8-9E96-63D001FBD7EBQ42368124-6C786A28-FFDA-4774-BB8E-7C2530604F0BQ43241737-D4E6FF6A-0345-4C44-9A99-96920826D14CQ48375195-5C50F148-5361-4795-A38F-8A3CB184EE74Q54255292-10366A61-C5F1-4058-8053-0638943B82A8
P2860
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Translating PrEP effectiveness ...... stice and advocacy for access.
@ast
Translating PrEP effectiveness ...... stice and advocacy for access.
@en
type
label
Translating PrEP effectiveness ...... stice and advocacy for access.
@ast
Translating PrEP effectiveness ...... stice and advocacy for access.
@en
prefLabel
Translating PrEP effectiveness ...... stice and advocacy for access.
@ast
Translating PrEP effectiveness ...... stice and advocacy for access.
@en
P2860
P356
P1476
Translating PrEP effectiveness ...... stice and advocacy for access.
@en
P2093
Mitchell Warren
Ruth Macklin
P2860
P356
10.7448/IAS.18.4.19973
P433
P577
2015-07-20T00:00:00Z